US FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine stating not enough supporting evidence for treating COVID-19

In light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine were felt to no longer outweigh the known and potential risks for the authorised use.


US Food and Drug Administration